Join us in the fight against blood cancer at The 2020 Red & White Ball – Celebrating LLS’s 70-Year Anniversary – a legacy that has brought us closer than ever to the cures for blood cancers, other cancers – and even other diseases for families today and generations to come.
Can’t attend the event? Make a donation now to our Mission Moment and be recognized in our event program.
FUNDS RAISED SUPPORT THE LEUKEMIA & LYMPHOMA SOCIETY’S CHILDREN’S INITIATIVE
Our goal is a wholesale shift in the standard of care for pediatric patients, moving from toxic chemotherapies that leave survivors with lifelong health challenges, to effective, safe treatments that precisely target cancer without harm to the rest of the child’s body.
What is The LLS Children’s Initiative?
The Leukemia & Lymphoma Society (LLS) is taking on children’s cancer from every direction, disrupting the status quo with our bold vision for young patients: to not only survive their cancer, but thrive in their lives after treatment.
The LLS Children’s Initiative is a comprehensive $100 million multi-year endeavor to help children with cancer through every facet of our mission:
- More than doubling our investment in pediatric cancer research grants
- Expanding education and support services for children and families
- Advocating for and driving policies to accelerate the development of new treatments and break down barriers to care
- Launching LLS PedAL (Pediatric Acute Leukemia), a groundbreaking global precision medicine clinical trial in acute pediatric leukemia
The need is urgent. Children are not mini-adults and we need to do better.
Blood cancers account for more than 40 percent of all childhood cancers, and most children are treated with the same toxic combinations of chemotherapies developed decades ago. Too many children succumb to their cancer, and many who survive are left with lifelong complications. Though there has been significant progress in advancing new therapies for adults with cancer, only four oncology drugs have been approved for first-use in children over the past four decades.